OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents
Jingqian Su, Yingsheng Luo, Shan Hu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13381-13381
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Vitamin K: Infection, Inflammation, and Auto-Immunity
Yuanyuan Xie, Shifang Li, Dinan Wu, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 1147-1160
Open Access | Times Cited: 9

Recent advances and structure-activity relationship studies of DPP-4 inhibitors as anti-diabetic agents
Shipra Singhal, Vaishali M. Patil, Saroj Verma, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107277-107277
Closed Access | Times Cited: 6

Novel Micro-Ribonucleic Acid Biomarkers for Early Detection of Type 2 Diabetes Mellitus and Associated Complications—A Literature Review
Sara Ahmed, Haroon Adnan, Mohammad Athar Khawaja, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 753-753
Open Access

Unlocking the Multifaceted Roles of GLP-1: Physiological Functions and Therapeutic Potential.
Tohada M. AL‐Noshokaty, Rehab Abdelhamid, Nourhan M. Abdelmaksoud, et al.
Toxicology Reports (2025) Vol. 14, pp. 101895-101895
Open Access

Association of P2X7 polymorphisms on Type 2 diabetes mellitus susceptibility and diabetic complications
G.-Y. Huang, Jing Cheng, Wenfeng Liu, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0318134-e0318134
Open Access

Recent advances in medicinal and edible homologous plant polysaccharides: Preparation, structure and prevention and treatment of diabetes
Lan Li, Jingchen Xie, Zhimin Zhang, et al.
International Journal of Biological Macromolecules (2023) Vol. 258, pp. 128873-128873
Closed Access | Times Cited: 13

Novel sulfonyl hydrazide based β-carboline derivatives as potential α-glucosidase inhibitors: design, synthesis, and biological evaluation
Jinping Sun, Di Xiao, Ming Lang, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 3

Advances in small-molecule insulin secretagogues for diabetes treatment
Jingqian Su, Jingran Xu, Shan Hu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117179-117179
Open Access | Times Cited: 2

The Anti-Diabetic Potential of Baicalin: Evidence from Rodent Studies
Tomasz Szkudelski, Katarzyna Szkudelska
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 431-431
Open Access | Times Cited: 7

Tetrazoles and Related Heterocycles as Promising Synthetic Antidiabetic Agents
Ростислав Е. Трифонов, В. А. Островский
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17190-17190
Open Access | Times Cited: 6

Study on Isoquercitrin Relieving Insulin Resistance of RNF6 Overexpressing db/db Mice
Yingjia Li, Sihua Lu, Junyu Meng, et al.
Frontiers in Medical Science Research (2024) Vol. 6, Iss. 3
Open Access | Times Cited: 1

Linking MDA Levels and Blood Glucose in Streptozotocin-Induced Rat Diabetes: Implications for Diabetic Complications and Therapeutic Strategies
Evelyn Angie, Ermi Girsang, Refi Ikhtiari
Jurnal Penelitian Pendidikan IPA (2024) Vol. 10, Iss. 6, pp. 2898-2905
Open Access | Times Cited: 1

A systematic review and meta-analysis of ischemia-modified albumin in diabetes mellitus
Angelo Zinellu, Arduino A. Mangoni
Heliyon (2024) Vol. 10, Iss. 16, pp. e35953-e35953
Open Access | Times Cited: 1

Exploring cutting-edge approaches in diabetes care: from nanotechnology to personalized therapeutics
Gihan F. Asaad, Ahmed S. Doghish, Ahmed A. Rashad, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Open Access | Times Cited: 1

Supramolecular approach to the design of nanocarriers for antidiabetic drugs: targeted patient-friendly therapy
Л. А. Васильева, Gulnara A. Gaynanova, E. A. Romanova, et al.
Russian Chemical Reviews (2024) Vol. 93, Iss. 11, pp. RCR5150-RCR5150
Closed Access | Times Cited: 1

The Safety and Efficacy of Combining Saxagliptin and Pioglitazone Therapy in Streptozocin-Induced Diabetic Rats
Ahmed Mohamed Othman, Ibrahim Ashour Ibrahim, Samy M. Saleh, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3300-3300
Open Access | Times Cited: 3

Comparative study of type 2 diabetes mellitus-associated gut microbiota between the Dai and Han populations
Ling-tong Tang, Lei Feng, Huiying Cao, et al.
World Journal of Diabetes (2023) Vol. 14, Iss. 12, pp. 1766-1783
Open Access | Times Cited: 2

Potential of FGF21 in type 2 diabetes mellitus treatment based on untargeted metabolomics
Shuai Li, Zi‐Long Song, Chunxiang Fan, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116306-116306
Closed Access

Network pharmacology, molecular docking and experimental validation to elucidate the anti-T2DM mechanism of Lanxangia tsaoko
Zhen Wang, Ruonan Li, Xiaoli Chen, et al.
Fitoterapia (2024) Vol. 178, pp. 106117-106117
Closed Access

Pink1 gene: a key player in the pathophysiology of type 2 diabetes mellitus
Khuzin Dinislam, Pozdnyakov Egor, Hezheva Arina, et al.
Egyptian Pharmaceutical Journal (2024) Vol. 23, Iss. 4, pp. 571-581
Closed Access

Prediction of Protein-Drug Interactions, Pharmacophore Modeling, and Toxicokinetics of Novel Leads for Type 2 Diabetes Treatment
Anuradha Mehra, Amit Mittal, Prakhar Kumar Vishwakarma
Current Drug Metabolism (2024) Vol. 25, Iss. 5, pp. 355-380
Closed Access

Lactobacillus rhamnosus ZJUIDS07 ameliorates type 2 diabetes in mice through the microbiome-gut-pancreas axis
Zeyu Wu, Jiting Gao, Chongwei Yu, et al.
Food Bioscience (2024), pp. 105297-105297
Closed Access

Page 1 - Next Page

Scroll to top